Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
Overactive bladder (OAB) is a chronic disease with the symptoms of urgency with or without incontinence. Solifenacin is an antimuscarinic drug that Excels in OAB treatment due to its specific bladder receptor targeting. While previous research had positive outcomes, reports of adverse events (AEs) h...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| סדרה: | Urology Annals |
| נושאים: | |
| גישה מקוונת: | https://journals.lww.com/10.4103/ua.ua_30_24 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|